Enbrel soluble TNF receptor data

IMNX reported additional data from an ongoing Phase II open-label long-term safety trial of Enbrel in patients with RA

Read the full 196 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE